Related Experiment Video
Updated: Aug 13, 2026

Analytical Determination of Mitochondrial Function of Excised Solid Tumor Homogenates
Published on: August 6, 2021
Antibiotic inhibitors of mitochondrial ATP synthesis
Abstract:
Fourteen antibiotics have been found to inhibit oxidative phosphorylation and uncoupler-stimulated adenosinetriphosphatase in mitochondria. Four different types of binding sites for these inhibitors have been found. The first (1) binds aurovertin to purified MF1 ATPase in the stoichiometric ratio of two aurovertin molecules per molecule of ATPase. Site II is the locus for efrapeptin (A23871) and may be a catalytic site on purified ATPase. The remaining two sites have been demonstrated only in mitochondria or submitochondrial particles when the APTase is bound to other membrane components. Oligomycin, venturiciden, venturicidin X and ossamycin probably all bind at site III. Leucinostatin (A20668) binds at site IV. At low concentrations, this antibiotic acts like oligomycin; at higher concentrations it uncouples oxidative phosphorylation. Venturicidin appears to prevent leucinostation from binding at site IV for it allows uncoupling to occur at very low concentrations of the latter antibiotic. Venturicidin aglycone, which is a more effective inhibitor than its parent compound, does not exert this effect. It is concluded that sites III and IV are in juxtaposition and that when venturicidin binds at site III its sugar moiety projects into the area of site IV to prevent leucinostation from binding at its inhibitory site.
Insights
Fourteen antibiotics inhibit mitochondrial ATP synthase by binding to four distinct sites. Venturicidin at site III interferes with leucinostatin binding at site IV, revealing their proximity and interaction.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Mitochondrial ATP synthase is crucial for cellular energy production.
- Antibiotics targeting ATP synthase can disrupt oxidative phosphorylation.
- Understanding inhibitor binding sites is key to developing targeted therapies.
Purpose of the Study:
- To identify and characterize the binding sites of various antibiotics on mitochondrial ATP synthase.
- To elucidate the mechanism of interaction between different antibiotic binding sites.
Main Methods:
- Biochemical assays using purified MF1 ATPase and submitochondrial particles.
- Stoichiometric analysis of inhibitor binding.
- Assessment of antibiotic effects on ATP synthase activity and oxidative phosphorylation.
Main Results:
- Four distinct binding sites (I, II, III, IV) for antibiotics were identified on ATP synthase.
- Aurovertin binds to site I, efrapeptin to site II.
- Oligomycin, venturicidin, and ossamycin bind to site III; leucinostatin binds to site IV.
- Venturicidin binding at site III inhibits leucinostatin binding at site IV, suggesting spatial proximity.
Conclusions:
- Mitochondrial ATP synthase possesses multiple antibiotic binding sites with distinct properties.
- Sites III and IV are closely located, and venturicidin's interaction with site III influences leucinostatin's binding at site IV.
- This interaction provides insights into the allosteric regulation of ATP synthase activity by inhibitors.
More Related Videos
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
ATP Synthase: Mechanism
The Electron Transport Chain
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q in...
The ADP/ATP Carrier Protein
Inhibitors of Bacterial Protein Synthesis
Inhibitors of Bacterial DNA Synthesis

